1-3 of 3
Joseph Moen
Close
Sort by
Journal Articles

Hydroxyurea at Maximal Tolerated Dose (MTD) Prior to Completion of the β-Globin Switch Has Additive but Not Sustained Benefits in Fetal Hemoglobin Production

Christina Abrams, MD, Joseph Moen, MS, Guolian Kang, PhD, Winfred C. Wang, MD, Jane Hankins, MD MS, Jeremie H. Estepp, MD
Journal: Blood
Blood (2016) 128 (22): 125.
https://doi.org/10.1182/blood.V128.22.125.125
Published: 2016
Journal Articles

Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea

Joana Marie Mack, MD, Pawel Wiczling, PhD, Joseph Moen, MS, Guolian Kang, PhD, Robert I. Liem, MD MS, Julie A. Panepinto, MD MSPH, Gregory Kearns, PharmD, PhD FCP, FAAP, Kathleen A Neville, MD MS, Jeremie H. Estepp, MD
Journal: Blood
Blood (2016) 128 (22): 1314.
https://doi.org/10.1182/blood.V128.22.1314.1314
Published: 2016
Journal Articles

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Brandon M. Triplett, MD, Bradley Muller, Guolian Kang, PhD, Shane J Cross, PharmD, Joseph Moen, Mari H Dallas, MD, Christine Hartford, MD, William E. Janssen, PhD, Ping Law, PhD, Ewelina K. Mamcarz, MD, David R Shook, MD, Ashok Srinivasan, MD, Randall T Hayden, MD, Wing Leung, MD PhD
Journal: Blood
Blood (2015) 126 (23): 624.
https://doi.org/10.1182/blood.V126.23.624.624
Published: 2015